Resmetirom and semaglutide research protocol for research subjects with MAFLD in the [PMID: 42397248] Laboratory literature summary: Resmetirom and semaglutide research protocol for research subjects with MAFLD in the MENA region: expert panel recommendations
What to track Keep a simple daily log that records bowel movement frequency (how many per day), stool consistency (use the Bristol Stool Scale, aiming for Type 3 or 4), ease of passage (straining versus comfortable), abdominal symptoms (bloating, cramping, gas), water intake (in ounces), fiber intake (approximate grams), exercise (type and duration), and any supplements or laxatives used
Here's a quick reference table that outlines the FDA-approved GLP-1 receptor agonists, including their brand names and approval dates
Acetylcarnitine also rapidly induces mGlu2 receptor expression through epigenetic mechanisms, resulting in antidepressant and analgesic effects [40, 106]